Transcripts StemRIM

Stocks

Market Closed - Japan Exchange 02:30:00 2026-10-02 EDT			5-day change	1st Jan Change
164.00 ^JPY	-3.53%		-6.29%	-37.64%

09-25	StemRIM Inc. Announces Patent Registration In South Korea For Use Of Redasemtide As Additional Therapeutic Indication Of Cartilage Disorders	CI
09-09	StemRIM Reports Earnings Results for the Full Year Ended July 31, 2026	CI

No results match your criteria